Correction to: Scientific Reports https://www.doi.org/10.1038/s41598-020-64421-6, published online 04 May 2020
This Article contains a typographical error in the Discussion section where all instances of “ECOG PS 2” should read “ECOG PS 2”.
. 2020 Nov 13;10:20199. doi: 10.1038/s41598-020-77250-4
Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
Yung-Yeh Su
1,2,3,#, Nai-Jung Chiang
1,2,3,#, Hui-Jen Tsai
1,2, Chia-Jui Yen
2, Yan‐Shen Shan
3,4,✉, Li‐Tzong Chen
1,2,5
Yung-Yeh Su
1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
2Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Find articles by Yung-Yeh Su
Nai-Jung Chiang
1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
2Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Find articles by Nai-Jung Chiang
Hui-Jen Tsai
1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
2Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Find articles by Hui-Jen Tsai
Chia-Jui Yen
2Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Find articles by Chia-Jui Yen
Yan‐Shen Shan
3Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4College of Medicine, National Cheng Kung University, Tainan, Taiwan
Find articles by Yan‐Shen Shan
Li‐Tzong Chen
1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
2Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
5Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan
Find articles by Li‐Tzong Chen
1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
2Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4College of Medicine, National Cheng Kung University, Tainan, Taiwan
5Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan
✉
Corresponding author.
#
Contributed equally.
Collection date 2020.
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC7666201 PMID: 33188263
This corrects the article "The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort", 7420.